RecruitingNCT06250998

Prediction of Abdominal Aortic Aneurysm Shrinkage After Stent-placement With Artificial Intelligence

Prediction of Abdominal Aortic Aneurysm Shrinkage After Endovascular Repair With Artificial Intelligence

Sponsor

Rijnstate Hospital

Enrollment

1,000 participants

Start Date

Apr 3, 2024

Study Type

OBSERVATIONAL

Conditions

AAA - Abdominal Aortic Aneurysm

Summary

The goal of this observational study is to find out what factors contribute to a good treatment outcome in patients who have received a stent for their dilation of the main abdominal artery (abdominal aortic aneurysm or AAA). The primary goal of this study is to build a prediction model for abdominal aortic aneurysm shrinkage one year after the treatment.

Eligibility

Min Age: 18 Years

Inclusion Criteria5

Age ≥ 18 years;
Elective, initially technically successful (as described by the ESVS guidelines11), infrarenal EVAR for unruptured infrarenal AAA;
Implanted endograft is a Gore Excluder, Medtronic Endurant, Cook Zenith, Cordis Incraft, Endologix AFX, Jotec E-Tegra, or Vascutek Anaconda endograft;
Follow-up of the AAA of at least one year with imaging of the same modality as the preoperative imaging;
Axial reconstructions of preoperative CT angiography available, preferably in the arterial phase and with 3 mm or smaller slice thickness.

Exclusion Criteria5

Patients with ruptured or symptomatic AAA;
Patients that were treated with fenestrated or branched endografts, iliac branched devices, non-CE marked devices within trial setting, other endografts (EVAS cases) or chimney procedures;
Acute procedures;
Reintervention before one year follow-up;
Revision cases after previous open or endovascular aneurysm repair of an AAA;

Interested in this trial?

Get notified about updates and connect with the research team.